Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy
Status:
Terminated
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This trial is aimed to study the efficacy of 4 weekly cycles of rituximab in HIV-infected
patients with multicentric Castleman disease (giant lymph node hyperplasia) dependent on
chemotherapy. Efficacy is assessed by the complete response rate at day 60. The patients are
followed until day 365.
Phase:
Phase 2
Details
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis